LANTHEUS HOLDINGS INC. - COMMON STOCK

Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel Technetium-99m SPECT/CT Imaging Agent, to Assess PD-L1 Expression for Immunotherapy in Cancer

13 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Lantheus’ PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency While Maintaining Accuracy for Assessment of PSMA Imaging in Prostate Cancer

13 Jun 2022 07:45:00 By Nasdaq GlobeNewswire

Lantheus to Present at the Jefferies Healthcare Conference

02 Jun 2022 08:30:00 By Nasdaq GlobeNewswire

Lantheus Announces Presentations Featuring PYLARIFY® (Piflufolastat F18), PYLARIFY AI™ and NM-01 (PD-L1 Imaging) at the 2022 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

26 May 2022 08:00:01 By Nasdaq GlobeNewswire

Lantheus Hosts Inaugural Investor Day

16 May 2022 16:30:00 By Nasdaq GlobeNewswire

Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological Association (AUA) Annual Meeting

16 May 2022 08:00:01 By Nasdaq GlobeNewswire

Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients

13 May 2022 08:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer

11 May 2022 08:00:01 By Nasdaq GlobeNewswire

Lantheus to Present at the UBS Global Healthcare Conference

10 May 2022 08:30:01 By Nasdaq GlobeNewswire

Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results

29 Apr 2022 07:07:25 By Nasdaq GlobeNewswire

Lantheus Holdings to Host First Quarter 2022 Earnings Conference Call and Webcast on April 29, 2022 at 8:00 a.m. Eastern Time

15 Apr 2022 08:30:00 By Nasdaq GlobeNewswire

Lantheus Appoints Jean-Claude Provost, MD as Interim Chief Medical Officer

04 Apr 2022 08:00:01 By Nasdaq GlobeNewswire

Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development

29 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Lantheus Holdings to Present at the Barclays Global Healthcare Conference

08 Mar 2022 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Host Inaugural Investor Day

03 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member

01 Mar 2022 16:05:01 By Nasdaq GlobeNewswire

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

24 Feb 2022 07:00:03 By Nasdaq GlobeNewswire

Lantheus Receives U.S. FDA Approval of New Manufacturing Facility

23 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting

10 Feb 2022 17:33:31 By Nasdaq GlobeNewswire

Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on February 24, 2022 at 8:00 a.m. Eastern Time

10 Feb 2022 08:30:00 By Nasdaq GlobeNewswire